Anthem Biosciences Limited

Anthem Biosciences Limited

730.35
+160.35
(28.13%)
Market Cap
32,011.80 Cr
EPS
9.05
PE Ratio
-
Dividend Yield
0.00 %
Industry
-
52 Week High
0.00
52 Week Low
0.00
PB Ratio
-
Debt to Equity
0.05
Sector
-
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Anthem Biosciences commenced trading at ₹723.05 per share, representing a premium over its issue price of ₹570. The stock opened higher than its initial public offering price on its trading debut.
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-8.09 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2023
2024
2025
TTM
Revenue
1,134
1,488
1,841
0
Expenses
628
913
1,152
0
EBITDA
506
575
689
0
Operating Profit %
41 %
36 %
37 %
0 %
Depreciation
64
82
78
0
Interest
7
9
9
0
Profit Before Tax
498
485
711
0
Tax
112
110
182
0
Net Profit
386
375
529
0
EPS in ₹
6.76
6.61
9.05
0.00

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
1,993
2,324
2,836
Fixed Assets
449
478
682
Current Assets
1,320
1,446
1,664
Capital Work in Progress
143
156
58
Investments
499
472
339
Other Assets
902
1,219
0
Total Liabilities
1,993
2,324
2,836
Current Liabilities
153
302
291
Non Current Liabilities
99
89
71
Total Equity
1,742
1,933
2,473
Reserve & Surplus
1,628
1,821
2,361
Share Capital
114
112
112

Cash Flow

Cash Flow
2021
2022
2023
Net Cash Flow
18
308
-6
Investing Activities
-196
-205
-376
Operating Activities
278
333
306
Financing Activities
-63
181
64

Share Holding

% Holding
Dec 2024
Jul 2025
Promoter
77.23 %
74.69 %
FIIs
0.00 %
0.00 %
DIIs
0.00 %
3.35 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
13.18 %
Others
22.77 %
8.78 %
No of Share Holders
16
8,25,844

Technical Indicators

RSI(14)
0.00
ATR(14)
0.00
STOCH(9,6)
0.00
STOCH RSI(14)
0.00
MACD(12,26)
0.00
ADX(14)
0.00
UO(9)
0.00
ROC(12)
0.00
WillR(14)
0.00